aromatase inhibition

Known as: Aromatase Inhibition Therapy, inhibition, aromatase 
Drug treatment to block the action of aromatases, thereby reducing estrogen biosynthesis.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Aromatase inhibitors (AIs) are widely used as an adjuvant endocrine treatment in postmenopausal women with early-stage breast… (More)
Is this relevant?
2006
2006
TO THE EDITOR: Approximately 1% of breast cancer occurs in male patients, yet little information is available on the optimal… (More)
Is this relevant?
Review
2005
Review
2005
The development of the novel third-generation aromatase inhibitors and inactivators for breast cancer treatment is one of the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Adding clomiphene citrate (CC) to FSH for controlled ovarian stimulation (COS) decreases FSH dose required for optimum… (More)
  • table I
  • table II
  • table III
  • table IV
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
We orally administered polyphenone-60 (P-60), green tea extract catechins, in the diet (0, 1.25 and 5%) to male rats for 2, 4 and… (More)
Is this relevant?
2002
2002
BACKGROUND First and second-generation aromatase inhibitors have shown activity in patients with androgen-independent prostate… (More)
Is this relevant?
Review
2001
Review
2001
For the cellular physiology of sex steroid sensitive cells, the androgen/estrogen ratio may be more important than only one… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The effect of exemestane (6-methylenandrosta-1,4-diene-3,17-dione) 25 mg p.o. once daily on in vivo aromatization was studied in… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The effect of anastrozole ('Arimidex', ZD1033), a new, selective, non-steroidal aromatase inhibitor on in vivo aromatisation and… (More)
  • table II
  • figure 1
  • table I
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Thirteen postmenopausal women with advanced breast cancer were enrolled in an open randomized Phase I trial of a new p.o. active… (More)
  • table I
  • table 2
  • figure 1
Is this relevant?